(Q61868248)
Statements
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response (English)
J M Foran
R K Gupta
R A Popescu
J W Sweetenham
R Pettengell
P W Johnson
E Bessell
B Hancock
K Summers
J Hughes
A Z Rohatiner